Resources
Registration and ordering
Alberta Precision Labs (APL) pharmacy information package and enrollment checklist
Enrollment Checklist for COVID-19 Asymptomatic Testing Program
APL Health Care Provider Information Form
APL Specimen Collection Kit Order Form
Pharmacy Asymptomatic COVID-19 Testing Program Change Request Form
In pharmacy processes
Patient Checklist - Pharmacy asymptomatic testing program
Pharmacy Asymptomatic Testing Consent Script
Targeted asymptomatic COVID-19 testing (Benefact 897)
Test requisitions
COVID-19 Test Requisition (Pharmacy – Calgary Zone)
COVID-19 Test Requisition (Pharmacy – Central Zone)
COVID-19 Test Requisition (Pharmacy – Edmonton Zone)
COVID-19 Test Requisition (Pharmacy – North Zone)
COVID-19 Test Requisition (Pharmacy – South Zone)
Paxlovid™
Reference guide for pharmacists dispensing Paxlovid™.
Paxlovid™ - Information Session for Community Pharmacy in Alberta – January 27, 2022 [Video]
FAQ
Online Pharmacy Locator Tool – Site Information
Pharmacy-based Asymptomatic COVID-19 Testing Program information
Pharmacy-based Asymptomatic COVID-19 Testing FAQ
Alberta Blue Cross® claiming process (Benefact 870).
Further information on Pharmacy-based Asymptomatic COVID-19 testing program (Benefact 892)
Alberta pharmacies
Reference Guide for the 2022-23 Alberta Influenza Immunization Program
Critical Supply Product List (PDF) | (Excel)
Nutritional Product, Package Size, and UPC Listing (PDF) | (Excel)
Alberta Blue Cross® Guide to Step Therapy
Alberta Blue Cross® Standard Maximum Allowable Cost (MAC) Drugs and Reference Price Listing
ASEBP TARP Drugs and Reference Price Listing
ASEBP member FAQs regarding TARP policy
Frequent Dispensing Policy Q&As
Maintenance Medication Program Drug Listing
Pharmacist Prescriber Special Authorization Registration Form
Healthcare Professionals Guide – May 1, 2021
Patient Information Sheet – September 29, 2021
Patient Supports – August 30, 2021
Addition of insulin aspart biosimilar – all adult patients on NovoRapid must switch by April 1, 2022 – September 29, 2021
Addition of insulin lispro biosimilar – all adult patients on Humalog must switch by February 1, 2022 – August 1, 2021
Addition of enoxaparin biosimilars – all adult patients on Lovenox must switch by January 10, 2022 – June 1, 2021
Addition of adalimumab biosimilars – all adult patients on Humira must switch by May 1, 2022 – May 1, 2021
Addition of etanercept biosimilar for the indication of plaque psoriasis – November 2, 2020
Physician reminder biosimilars initiative – October 7, 2020
Addition of rituximab and pegfilgrastim biosimilars – September 1, 2020
New information – switch deadline extended to January 15, 2021